40 Chapter 2 24. Scherr C, Cunha AB da, Magalhães CK, Abitibol RA, Barros M, Cordovil I. Life-habit intervention in a public institution. Arq Bras Cardiol. 2010;94(6):730–7. 25. Silveira AD, Ribeiro RA, Rossini APW, Stella SF, Ritta HAR, Stein R, et al. Association of anemia with clinical outcomes in stable coronary artery disease. Pathophysiol Nat Hist. 2005;19(1):21–6. 26. Gomes VO, Blaya P, Lasevitch R, Oliveira D, Hickmann P, Smidt L, et al. Original Article Impact of Chronic Kidney Disease on the Efficacy of Drug-Eluting Stent : Long-term Follow-up Study. Arq Bras Cardiol. 2011;96(5):346–51. 27. Villacorta AS, Junior HV, Batista MJS, Gomes RV, Augusto L, Helmuth B, et al. Original Article High On-Treatment Platelet Reactivity Predicts Cardiac Events in Patients with Drug-Eluting Stents. Arq Bras Cardiol. 2013;100(3):221–7. 28. Pesaro AEP, Serrano C V, Fernandes JL, Cavalcanti AB, Campos AH, Martins HS, et al. Pleiotropic effects of ezetimibe / simvastatin vs . high dose simvastatin. Int J Cardiol. 2012;158(3):400–4. 29. Santos VF, Braga F, Almeida Junior GLG, Faria P de MP, Gorgulho PCC, Faria MR dos SE, et al. Resistência ao AAS na doença coronariana estável. Int j Cardiovasc sci. 2015;28(5):363–9. 30. Kimura-medorima ST, Paula A, Lazaro B, Marcel P, Almeida C, Figueiredo MJO, et al. P-wave duration is a predictor for long-term mortality in post-CABG patients. 2018;1–13. 31. Breda JR, Silvia A, Ragognetti C, Cristina A, Freitas O, Tavares CM, et al. Effect of ventral cardiac denervation in the incidence of atrial fibrilation after coronary artery bypass graft surgery. 2008;23(2):204–8. 32. Ribeiro MS, Nascimento TCDC, Murakami B, Bergamasco EC, Lopes CT, Santos ER. Desfechos clínicos dos pacientes submetidos à intervenção coronária percutânea com stent bioabsorvível eluidor de everolimus. Medicina (B Aires). 2018;51(4):237–46. 33. Saffi MAL, Polanczyk CA, Rabelo-Silva ER. Lifestyle interventions reduce cardiovascular risk in patients with coronary artery disease : A randomized clinical trial. Eur J Cardiovasc Nurs. 2014;13(5):436–43. 34. Souza CF De, El Mouallem AM, Sândoli F, de Brito Júnior FS, Cunha Abizaid AA, Oliveira Almeida B, et al. Safety and efficacy of biolimus-eluting stent with biodegradable polymer : insights from EINSTEIN ( Evaluation of Nextgeneration drug-eluting STEnt IN patients with coronary artery disease ) Registry. Einstein. 2013;11(55 11):350–6. 35. Vilar CP, Cotrim HP, Florentino GSA, Bragagnoli G, Schwingel PA, Barreto CPV. Doença hepática gordurosa não alcoólica em pacientes com doença coronariana de uma área do nordeste do Brazil. Arq Gastroenterol. 2015;52(2):111–6. 36. Nery RM, Zanini M, Lima B De, Bühler P. Tai Chi Chuan improves functional capacity after myocardial infarction : A randomized clinical trial. Am Heart J. 2015;169(6):854–60. 37. Liberato ACS, Rodrigues RCM, São-João TM, Costa Alexandre NM, Bueno Jayme Gallani MC. Satisfaction with medication in coronary disease treatment : psychometrics of the Treatment Satisfaction Questionnaire for Medication. Rev Latino-Am Enfermagen. 2016;24:e2705. 38. Mattos LA, Berwanger O, Silva E, José H, Reis L, Guimarães JI, et al. Clinical Outcomes at 30 days in the Brazilian Registry of Acute Coronary Syndromes ( ACCEPT ). 2012;100(1):6–13. 39. Furuya RK, Arantes EC, Dessotte CAM, Ciol MA, Hoffman JM, Dantas RAS, et al. Randomized controlled trial of an educational programme to improve self-care in Brazilian patients following percutaneous coronary intervention. John Wiley Sons Ltd. 2014;895–908. 40. de Oliveira LMSM, Costa IMNB de C, da Silva DG, Silva JRSS, Barreto-Filho JAS, Almeida-Santos MA, et al. Readmission of patients with acute coronary syndrome and determinants. Arq Bras Cardiol. 2019;113(1):42–9. 41. Simon S, Coronel C, Silveira de Almeida A, Marcadenti A. Left lateral intercostal region versus subxiphoid position for pleural drain during elective coronary artery bypass graft surgery : randomized clinical trial. Sao Paulo Med J. 2019;137(1):66–74. 42. Chaves GSS, Lima G, Ghisi DM, Britto RR, Grace SL. Maintenance of Gains, Morbidity, and Mortality at 1 Year Following Cardiac Rehabilitation in a Middle-Income Country: A Wait-List Control Crossover Trial. J Am Heart Assoc. 2019;8:e011228. 43. Carvalho T De, Curi ALH, Andrade DF, Singer J da M, Benetti M, Mansur AJ. Cardiovascular Rehabilitation of Patients With Ischemic Heart Disease Undergoing Medical Treatment , Percutaneous Transluminal Coronary Angioplasty , and Coronary Artery Bypass Grafting. Arq Bras Cardiol. 2006;88(1):65–70. 44. Uchôa CHG, De Jesus Danzi-Soares N, Nunes FS, De Souza AAL, Nerbass FB, Pedrosa RP, et al. Impact of OSA on cardiovascular events aft er coronary artery bypass surgery. Chest. 2015;147(5):1352–60. 45. Lima-Filho GL, Foss MC. Predictors of restenosis after percutaneous coronary intervention using bare-metal stents . A comparison between patients with and without dysglycemia Predictors of restenosis after percutaneous coronary intervention using bare-metal stents . A comparison. Braz J Med Biol Res. 2010;43(6):572–9. 46. Cruz LN, Camey SA, Fleck MP, Polanczyk CA. World Health Organization quality of life instrument-brief and Short Form-36 in patients with coronary artery disease: Do they measure similar quality of life concepts? Psychol Heal Med. 2009;14(5):619–28.
RkJQdWJsaXNoZXIy MTk4NDMw